Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI ...

Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean technology provider specializing ...

Nvidia in 2022 agreed to pay $5.5 million to U.S. authorities to settle charges that it did not properly disclose the impact ...

Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA) today announced it will attend Truist Securities BioPharma Symposium on November 7 in New York, ...

International Paper has put a fine point on the timeline of shutting down its longtime Georgetown mill in coastal South ...

Investor AB has underperformed the S&P500 but remains a stable investment due to its diversified portfolio and buy-and-hold ...

Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent covering a variant of ...

Chemomab Therapeutics (CMMB) has released an update. Chemomab Therapeutics reported promising results from its Phase 2 SPRING trial for CM-101, ...

Over the last 12 months, AB's Forward P/E has been as high as 12.15 and as low as 9.62, with a median of 10.65. Investors will also notice that AB has a PEG ratio of 0.60. This figure is similar ...